Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO1997016199) METHODS FOR TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION WITH A SOLVENT EXTRACT DERIVED FROM PSEUDOMONAS
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1997/016199 International Application No.: PCT/US1996/017349
Publication Date: 09.05.1997 International Filing Date: 30.10.1996
Chapter 2 Demand Filed: 28.05.1997
IPC:
A61K 35/74 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35
Medicinal preparations containing material or reaction products thereof with undetermined constitution
66
Materials from micro-organisms
74
Bacteria
Applicants:
DYNAGEN, INC. [US/US]; 99 Erie Street Cambridge, MA 02139, US (AllExceptUS)
ISTRATE, Nicolae [US/US]; US (UsOnly)
MUNI, Gita [US/US]; US (UsOnly)
BRAUNER, Edgard [US/US]; US (UsOnly)
RAHEMAN, Fazal [IN/US]; US (UsOnly)
Inventors:
ISTRATE, Nicolae; US
MUNI, Gita; US
BRAUNER, Edgard; US
RAHEMAN, Fazal; US
Agent:
GATES, Edward, R.; Wolf, Greenfield & Sacks, P.C. 600 Atlantic Avenue Boston, MA 02210, US
KINDREGAN, Helen; Wolf, Greenfield & Sacks, P.C. 600 Atlantic Avenue Boston, MA 02210, US
Priority Data:
08/550,39330.10.1995US
Title (EN) METHODS FOR TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION WITH A SOLVENT EXTRACT DERIVED FROM PSEUDOMONAS
(FR) PROCEDES DE TRAITEMENT DE L'INFECTION PAR LE VIRUS DE L'IMMUNODEFICIENCE HUMAINE A L'AIDE D'UN EXTRAIT DE SOLVANT DERIVE DE PSEUDOMONAS
Abstract:
(EN) The present invention is directed to a method of treating individuals infected with HIV or at risk of being infected with HIV. The method comprises the step of administering to an individual infected with HIV or at risk of being infected with HIV, an effective amount of a solvent extract or active fraction thereof derived from bacteria. The solvent extract or active fraction thereof exhibits an immunomodulating effect in humans, promoting a stabilization or improvement in immune system function.
(FR) Procédé de traitement d'individus infectés par le VIH ou exposés au risque d'une telle infection. Ce procédé consiste à administrer à un individu infecté par le VIH, ou exposé au risque d'une telle infection, une dose efficace d'un extrait de solvant dérivé de bactéries, ou d'une fraction active d'un tel extrait. Cet extrait de solvant ou cette fraction active présente un effet immunomodulateur chez l'homme, ce qui favorise une stabilisation voire une amélioration des fonctions du système immunitaire.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CZ, DE, DK, EE, ES, FI, GB, GE, HU, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, TJ, TM, TR, TT, UA, UG, US, UZ, VN
African Regional Intellectual Property Organization (ARIPO) (KE, LS, MW, SD, SZ, UG)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
CA2236345AU1996075262